RSK3: A regulator of pathological cardiac remodeling-Reference-Cited by-同舟云学术

RSK3: A regulator of pathological cardiac remodeling

Published:2015-05 Issue:5 Volume:67 Page:331-337
ISSN:1521-6543
Container-title:IUBMB Life
language:en
Short-container-title:IUBMB Life

Author:

Martinez Eliana C.¹,Passariello Catherine L.¹,Li Jinliang¹,Matheson Christopher J.²,Dodge-Kafka Kimberly³,Reigan Philip²,Kapiloff Michael S.¹

Affiliation:

1. Cardiac Signal Transduction and Cellular Biology Laboratory; Interdisciplinary Stem Cell Institute; Division of Cardiology; Department of Pediatrics; Miller School of Medicine, University of Miami; Miami FL USA

2. Department of Pharmaceutical Sciences; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado; Aurora CO USA

3. Calhoun Center for Cardiology, University of Connecticut Health Center; Farmington CT USA

Funder

NIH

State of Florida James and Esther King Biomedical Research Program

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Genetics,Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/iub.1383/fullpdf

Reference79 articles.

1. Heart disease and stroke statistics-2014 update: a report from the American Heart Association;Go;Circulation,2014

2. Heart failure;Braunwald;JACC Heart Fail.,2013

3. Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium;Loffredo;Circ. Res.,2014

4. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies;Sharma;Circ. Res.,2014

5. c-Jun N-terminal kinase-interacting protein 1 inhibits gene expression in response to hypertrophic agonists in neonatal rat ventricular myocytes;Finn;Biochem. J.,2001

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Empagliflozin mitigates cardiac hypertrophy through cardiac RSK/NHE-1 inhibition;Biomedicine & Pharmacotherapy;2024-05

2. The Role of p90 Ribosomal S6 Kinase (RSK) in Tyrosine Kinase Inhibitor (TKI)-Induced Cardiotoxicity;Journal of Cardiovascular Translational Research;2023-09-19

3. mAKAPβ signalosome: A potential target for cardiac hypertrophy;Drug Development Research;2023-05-18

4. MYSM1 induces apoptosis and sensitizes TNBC cells to cisplatin via RSK3–phospho-BAD pathway;Cell Death Discovery;2022-02-26

5. Novel susceptibility loci identified in a genome-wide association study of type 2 diabetes complications in population of Latvia;BMC Medical Genomics;2021-01-11